Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novocure Ltd Ord Sh
(NQ:
NVCR
)
16.36
+0.33 (+2.06%)
Streaming Delayed Price
Updated: 1:08 PM EDT, May 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novocure Ltd Ord Sh
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...
Via
Benzinga
Recap: NovoCure Q3 Earnings
October 28, 2021
NovoCure (NASDAQ:NVCR) reported its Q3 earnings results on Thursday, October 28, 2021 at 06:00 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...
Via
Benzinga
Start Of 2022
January 03, 2022
Mohammed El Erien predicts that the Fed will be slamming on the brakes this year.
Via
Talk Markets
Stocks Hitting New 52-Week Lows Today
January 03, 2022
On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was...
Via
Benzinga
Happy New Year - Sunday Edition
January 02, 2022
Starting a new year - we look at tech, pharma and mining stocks and their goings-on.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
January 03, 2022
Upgrades For nVent Electric PLC (NYSE:NVT), Vertica...
Via
Benzinga
Market Trend: Erratic And Unreliable
December 29, 2021
Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is.
Via
Talk Markets
Plague Year Reversal
December 21, 2021
Just in time for Christmas, the market decided to go up today pretty much across the board.
Via
Talk Markets
Inflation Surge
December 10, 2021
Today the market failed to brush off inflation fears as it had done later on Thursday as inflation is at a 4 decade high.
Via
Talk Markets
recession in 2022?
December 06, 2021
China has cut its reserve requirement for lending by 50% giving a $188 bn boost to its market.
Via
Talk Markets
Topics
Economy
Exposures
Economy
Charms Of China
December 03, 2021
Today the global stock market rout was pretty awful.
Via
Talk Markets
Is It Time to Buy the 3 Worst-Performing Growth Stocks of 2021?
December 03, 2021
This year's big pullbacks are more the result of a raucous 2020, and less an indictment of these companies' prospects.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Tuesday Markets Review
November 30, 2021
The oil price did not fall as expected over the White House release of 50 mn bbls of oil.
Via
Talk Markets
Tuesday Markets Coverage
November 23, 2021
GE was up on hopes for cheaper oil. But most stocks were down on oil price hike fears.
Via
Talk Markets
Novocure Posts Data For Tumor Treating Fields In Brain Tumor Trial
November 15, 2021
Novocure Ltd (NASDAQ: NVCR) has released updated data from the Phase 2 pilot 2-THE-TOP of Tumor Treating Fields (TTFields) together with pembrolizumab and...
Via
Benzinga
What's the Outlook for Novocure?
November 13, 2021
There's a lot riding on clinical studies of the company's tumor treating fields product.
Via
The Motley Fool
3 Healthcare Stocks That Could Be Turkeys in November
October 29, 2021
You might want to avoid stuffing your portfolio with them.
Via
The Motley Fool
NovoCure (NVCR) Q3 2021 Earnings Call Transcript
October 28, 2021
NVCR earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
No Negative Reaction
October 28, 2021
Today the impact of the Delta variant hit US GDP which was only 2% annualized, vs estimates of 2.6%, based on Q3 data which came out today.
Via
Talk Markets
Why NovoCure Stock Is Sinking This Week
October 28, 2021
Investors weren't happy with the company's Q3 update.
Via
The Motley Fool
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
October 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...
Via
Benzinga
Bitcoin Futures Arrive
October 19, 2021
Today you can finally hold Bitcoins via an exchange-traded fund.
Via
Talk Markets
More Chinese Trouble
October 14, 2021
A day after the consumer price rise there was another price rise for producer markets.
Via
Talk Markets
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...
Via
Benzinga
Exposures
Product Safety
This Unstoppable Cancer-Treatment Company's Stock Is on Sale Now
October 14, 2021
Novocure's stock keeps sliding, but the company continues to perform.
Via
The Motley Fool
This Company's Device is Becoming Essential to Cancer Treatment -- Why Is the Stock Slumping?
October 12, 2021
Is it time to buy this stock nearly at its 52 week low?
Via
The Motley Fool
Cramer Likes Ford, But Suggests Waiting For Dips To Buy These Stocks
October 11, 2021
On Friday's "Mad Money Lightning ...
Via
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.